AIを活用した創薬・臨床試験市場レポート：2025-2035
AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035
概要
AIを活用した創薬と臨床試験市場レポート 2025-2035年： 本レポートは、業界とその基礎となる原動力をより深く理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでし... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
概要
AIを活用した創薬と臨床試験市場レポート 2025-2035年： 本レポートは、業界とその基礎となる原動力をより深く理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。また、異業種への進出や新規地域での既存事業の拡大を希望する企業にとっても有用です。
医薬品開発期間の短縮とコスト効率化が市場成長を牽引
AIを活用した創薬・臨床試験市場を推進している主な推進要因には、医薬品開発のタイムラインを短縮し、研究コストを削減し、業務効率を改善する能力が含まれる。AI技術は、標的同定、分子スクリーニング、臨床試験の最適化など、創薬のさまざまな段階を合理化し、より迅速で費用対効果の高い医薬品開発につながる。さらに、分子設計のための生成モデルや患者募集のための予測分析など、AI主導型プラットフォームの進歩が市場の成長をさらに押し上げると予想される。
例えば：
-
2025年3月24日、オックスフォード創薬研究所の研究者らは、AIを活用したデータベースを用いてアルツハイマー病の創薬を加速させた。膨大な生物医学データを効率的に分析することで、54の免疫系関連遺伝子を同定し、遺伝子評価に必要な時間を大幅に短縮し、有望な創薬ターゲットの同定を早めた。
-
2025年3月21日、アストラゼネカは5年間で25億ドルを投資し、AIとデータサイエンスの研究所を備えた研究・製造センターを北京に設立すると発表した。このイニシアチブは、創薬の迅速化と関連コストの削減を目指し、初期段階の研究と臨床開発を強化するためにAIを活用するという同社のコミットメントを強調するものである。
-
2025年1月8日、アドバンスト・マイクロ・デバイセズ社（AMD）は、AIを活用した創薬活動を強化するため、アブスキー社に2,000万ドルを投資した。この提携は、AMDの高度なコンピューティング能力を活用することで、生物製剤のイノベーションを迅速化し、コストを削減することを目的としており、従来の医薬品開発プロセスを変革する上でAIの役割が高まっていることを強調している。
しかし、一部の大手製薬会社は、データプライバシー、知的財産の損失、戦略的統制の低下に対する懸念から、AIを活用したアウトソーシングの全面的な導入に依然として躊躇している。このような懸念にもかかわらず、医薬品開発の複雑化は、社内業務のコスト上昇と相まって、多くの企業が効率とイノベーションを強化するためにAIソリューション・プロバイダーとの協業を推進している。また、新興国も重要な役割を果たしており、製薬企業はこれらの地域におけるより低い運用コストと高度なAI技術を活用しようとしている。
市場成長の妨げとなる規制とデータ統合の課題
AIの導入は大きなメリットをもたらすが、規制遵守、データ統合、標準化をめぐる課題が市場の成長を鈍らせる可能性がある。医薬品承認と患者データ保護に関する厳格な規制は、AIシステムに透明性と説明可能性を維持することを要求し、実装に複雑な層を追加する。さらに、多様なシステムや地域にわたって整合化されたデータの必要性は、AI対応プラットフォームにとって物流上の課題となる。
AIプラットフォームと臨床試験施設間のリアルタイムの連携を確保するには、堅牢なデータインフラとシームレスな統合も必要だ。例えば、個別化医療や希少疾患の臨床試験では、厳しい規制の枠組みを遵守しながら膨大なデータセットを管理できる高度なAIモデルが必要となる。AIの導入が進むにつれ、業界関係者は、創薬や臨床試験におけるAIの可能性を十分に実現するために、こうした管理面や技術面の課題をうまく乗り越えなければならない。
市場調査レポートを購入する前にすべき質問とは？
-
AIを活用した創薬・臨床試験市場はどのように進化しているのか？
-
AIを活用した創薬・臨床試験市場の推進要因と阻害要因は何か？
-
AIを活用した創薬・臨床試験の各サブマーケットは予測期間中にどのように成長し、2035年にはどれくらいの売上を占めるようになるのか。
-
2025年から2035年にかけて、AIを活用した創薬・臨床試験の各サブマーケットの市場シェアはどのように推移するのか？
-
2025年から2035年にかけて、市場全体を牽引する主な要因は何か？
-
AIを活用した有力な創薬・臨床試験市場は、マクロ経済の動きに幅広く追随するのだろうか、それとも個々の国の市場が他を凌駕するのだろうか。
-
2035年までに各国市場のシェアはどのように変化し、どの地域が2035年の市場をリードするのか。
-
主要プレーヤーと予測期間中の見通しは？
-
これらの大手企業におけるAIを活用した創薬・臨床試験プロジェクトとは？
-
2025年から2035年の間に、業界はどのように進化するのか？AIを活用した創薬・臨床試験プロジェクトは、現在、そして今後10年間でどのような意味を持つのか？
-
AIを活用した創薬・臨床試験市場をさらに拡大するために、製品化の必要性は高まっているのでしょうか？
-
AIを活用した創薬・臨床試験市場はどこに向かい、どのようにすれば市場の最前線に立てるのか。
-
新商品や新サービスに最適な投資方法とは？
-
企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？
AIを活用した創薬・臨床試験市場が現在、そして今後10年間でどのような影響を受けるかを知る必要がある：
-
285ページにわたる本レポートでは、107の表と155の図表を掲載しています。
-
本レポートでは、業界における主要な有利分野を取り上げているため、今すぐターゲットを絞ることができます。
-
世界、地域、国の売上と成長に関する詳細な分析が含まれています。
-
競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
2035年までの予測やその他の分析から、商業的な展望が見えてきた
-
2035年までの収益予測に加え、最新の実績、成長率、市場シェアも提供する。
-
ビジネスの展望や展開など、独自の分析が掲載されている。
-
質的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題など）、コスト構造、AIを活用した創薬・臨床試験価格上昇の影響、最新動向をご覧いただけます。
レポート対象セグメント
コンポーネント
用途
-
臨床試験
-
ドラッグデザイン
-
データの集計と分析
-
薬剤の特性
-
バイオマーカー研究
-
その他
治療分野
-
腫瘍学
-
心血管疾患
-
感染症
-
神経変性疾患
-
代謝性疾患
-
免疫学的疾患
-
その他
エンドユーザー
-
製薬・バイオ製薬企業
-
医薬品開発業務受託機関（CRO）
-
学術機関と研究センター
世界市場全体と各分野の収益予測に加え、5つの地域と24の主要国市場の収益予測も掲載している：
北米
欧州
-
ドイツ
-
英国
-
フランス
-
スペイン
-
ロシア
-
イタリア
-
その他の欧州地域
アジア太平洋
-
中国
-
日本
-
インド
-
オーストラリア
-
韓国
-
シンガポール
-
その他のアジア太平洋地域
ラテンアメリカ
-
ブラジル
-
メキシコ
-
アルゼンチン
-
コロンビア
-
その他のラテンアメリカ地域
MEA
本レポートでは、AIを活用した創薬・臨床試験市場の2025年から2035年にかけての主要企業のプロファイルも掲載しており、これらの企業の事業のこのセグメントに焦点を当てている。
報告書に掲載されている主要企業
-
AiCure
-
Aitia
-
Atomwise Inc.
-
BenevolentAI
-
Insilico Medicine
-
PathAI, Inc.
-
Recursion
-
Saama Technologies
-
Schrödinger, Inc.
-
Tempus
-
Unlearn.ai, Inc.
AIを活用した創薬・臨床試験市場の2025年から2035年までの世界全体の売上高は、金額ベースでは2025年に30億米ドルを突破するとの試算を発表した。2035年まで収益が大きく伸びると予測している。当社の調査では、最も大きな可能性を秘めた組織を特定しています。各社の能力、進捗状況、商業的見通しを把握し、一歩先を行くための一助としてください。
AIを活用した創薬と臨床試験市場、2025年から2035年までのレポートはどのように役立つのでしょうか？
要約すると、弊社の280ページを超えるレポートは以下の知識を提供します：
-
AIを活用した創薬と臨床試験市場の2025年から2035年までの収益予測 - 構成要素、用途、治療分野、エンドユーザーごとに世界と地域レベルで予測 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。
-
5つの地域と24の主要国市場の2035年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAにおけるAIを活用した創薬と臨床試験市場の2025年から2035年までの予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの著名経済圏の市場も予測しています。
-
既存企業および市場参入を目指す企業の展望 - AIを活用した創薬・臨床試験市場に関わる主要企業11社の企業プロファイルを含む、2025年から2035年までの市場。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。
ページTOPに戻る
目次
1 レポート概要
1.1 研究の目的
1.2 AIを活用した創薬・臨床試験市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートの対象者
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブ・サマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.3 影響分析
3.3.1 市場促進要因
3.3.1.1 個別化医療への注目の高まり
3.3.1.2 技術の進歩
3.3.1.3 医療におけるAIの採用拡大
3.3.2 市場抑制要因
3.3.2.1 限られたデータの入手可能性と質
3.3.2.2 既存のインフラとの統合
3.3.2.3 データのプライバシーとセキュリティに対する懸念
3.3.3 市場機会
3.3.3.1 患者転帰の改善
3.3.3.2 製薬・バイオ医薬品臨床試験におけるAI導入の増加
3.3.3.3 共同研究やパートナーシップの拡大
3.4 規制の枠組み
3.5 新興市場とメガトレンド
3.6 ポーターのファイブフォース分析
3.6.1 サプライヤーの交渉力
3.6.2 買い手の交渉力
3.6.3 競争上のライバル関係
3.6.4 代替品の脅威
3.6.5 新規参入企業の脅威
3.7 PEST分析
4 AIを活用した創薬・臨床試験市場分析：コンポーネント別
4.1 主要な調査結果
4.2 コンポーネントセグメント 市場魅力度指数
4.3 AIを活用した創薬・臨床試験市場コンポーネント別市場規模の推定と予測
4.4 サービス
4.4.1 2025〜2035年の地域別市場規模（百万米ドル）
4.4.2 地域別市場シェア、2025年・2035年(%)
4.5 ソフトウェアソリューション
4.5.1 2025～2035年の地域別市場規模（百万米ドル）
4.5.2 地域別市場シェア、2025年・2035年 (%)
5 AIを活用した創薬・臨床試験市場分析：用途別
5.1 主要な調査結果
5.2 アプリケーションセグメント 市場魅力度指数
5.3 AIを活用した創薬・臨床試験市場用途別市場規模の推定と予測
5.4 臨床試験
5.4.1 2025〜2035年の地域別市場規模（百万米ドル）
5.4.2 地域別市場シェア、2025年・2035年(%)
5.5 ドラッグデザイン
5.5.1 2025〜2035年地域別市場規模（百万米ドル）
5.5.2 地域別市場シェア、2025年・2035年(%)
5.6 データ集約と分析
5.6.1 2025～2035年の地域別市場規模（百万米ドル）
5.6.2 地域別市場シェア、2025年・2035年(%)
5.7 医薬品の特性解析
5.7.1 2025〜2035年の地域別市場規模（百万米ドル）
5.7.2 地域別市場シェア、2025年・2035年(%)
5.8 バイオマーカー研究
5.8.1 2025～2035年の地域別市場規模（百万米ドル）
5.8.2 地域別市場シェア、2025年・2035年(%)
5.9 その他
5.9.1 2025〜2035年地域別市場規模（百万米ドル）
5.9.2 地域別市場シェア、2025年・2035年 (%)
6 AIを活用した創薬・臨床試験市場分析：治療分野別
6.1 主な調査結果
6.2 治療領域セグメント 市場魅力度指数
6.3 AIを活用した創薬・臨床試験市場治療領域別市場規模の推定と予測
6.4 がん領域
6.4.1 2025〜2035年の地域別市場規模（百万米ドル）
6.4.2 地域別市場シェア、2025年・2035年(%)
6.5 循環器疾患
6.5.1 2025〜2035年の地域別市場規模（百万米ドル）
6.5.2 地域別市場シェア、2025年・2035年(%)
6.6 感染症
6.6.1 2025〜2035年の地域別市場規模（百万米ドル）
6.6.2 地域別市場シェア、2025年・2035年(%)
6.7 神経変性疾患
6.7.1 2025〜2035年の地域別市場規模（百万米ドル）
6.7.2 地域別市場シェア、2025年・2035年(%)
6.8 代謝性疾患
6.8.1 2025〜2035年の地域別市場規模（百万米ドル）
6.8.2 地域別市場シェア、2025年・2035年(%)
6.9 免疫疾患
6.9.1 2025〜2035年の地域別市場規模（百万米ドル）
6.9.2 地域別市場シェア、2025年・2035年(%)
6.10 その他
6.10.1 地域別市場規模、2025年〜2035年（百万米ドル）
6.10.2 地域別市場シェア、2025年・2035年 (%)
7 AIを活用した創薬・臨床試験市場分析：エンドユーザー別
7.1 主要な調査結果
7.2 エンドユーザーセグメント 市場魅力度指数
7.3 エンドユーザー別のAIを活用した創薬・臨床試験市場規模の推定と予測
7.4 製薬・バイオ医薬品企業
7.4.1 2025年〜2035年の地域別市場規模（百万米ドル）
7.4.2 地域別市場シェア、2025年・2035年(%)
7.5 CRO（医薬品開発業務受託機関）
7.5.1 2025年～2035年の地域別市場規模（百万米ドル）
7.5.2 地域別市場シェア、2025年・2035年(%)
7.6 学術機関・研究センター
7.6.1 2025～2035年の地域別市場規模（百万米ドル）
7.6.2 地域別市場シェア、2025年・2035年(%)
8 AIを活用した創薬・臨床試験市場分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推定と予測
9 北米のAIを活用した創薬・臨床試験市場の分析
9.1 主要な調査結果
9.2 北米のAIを活用した創薬・臨床試験市場魅力度指数
9.3 北米のAIを活用した創薬・臨床試験市場の国別市場規模、2025年、2030年、2035年（百万米ドル）
9.4 北米のAIを活用した創薬・臨床試験市場の国別規模推定と予測
9.5 北米のAIを活用した創薬・臨床試験市場規模推定と予測：コンポーネント別
9.6 北米のAIを活用した創薬・臨床試験市場規模推定と予測：用途別
9.7 北米のAIを活用した創薬・臨床試験市場規模推定と予測：治療分野別
9.8 北米のAIを活用した創薬・臨床試験市場規模推定と予測：エンドユーザー別
9.9 米国のAIを活用した創薬・臨床試験市場分析
9.10 カナダのAIを活用した創薬と臨床試験の市場分析
10 欧州のAIを活用した創薬・臨床試験市場分析
10.1 主要な調査結果
10.2 欧州のAIを活用した創薬・臨床試験市場魅力度指数
10.3 欧州のAIを活用した創薬・臨床試験市場の国別市場規模、2025年、2030年、2035年（百万米ドル）
10.4 欧州のAIを活用した創薬・臨床試験市場規模国別推定と予測
10.5 欧州のAIを活用した創薬・臨床試験市場規模推定と予測：コンポーネント別
10.6 欧州のAIを活用した創薬・臨床試験市場規模推定と予測：用途別
10.7 欧州のAIを活用した創薬・臨床試験市場規模推定と予測：治療分野別
10.8 欧州のAIを活用した創薬と臨床試験市場規模推定と予測：エンドユーザー別
10.9 ドイツのAIを活用した創薬・臨床試験市場分析
10.10 イギリスのAIを活用した創薬・臨床試験市場の分析
10.11 フランスのAIを活用した創薬と臨床試験の市場分析
10.12 イタリアのAIを活用した創薬と臨床試験の市場分析
10.13 スペインのAIを活用した創薬と臨床試験の市場分析
10.14 ロシアのAIを活用した創薬と臨床試験の市場分析
10.15 その他の欧州のAIを活用した創薬と臨床試験の市場分析
11 アジア太平洋地域のAIを活用した創薬・臨床試験市場分析
11.1 主要な調査結果
11.2 アジア太平洋地域のAIを活用した創薬・臨床試験市場魅力度指数
11.3 アジア太平洋地域のAIを活用した創薬・臨床試験市場の国別市場規模、2025年、2030年、2035年（百万米ドル）
11.4 アジア太平洋地域のAIを活用した創薬・臨床試験市場の国別規模推定と予測
11.5 アジア太平洋地域のAIを活用した創薬・臨床試験市場規模推定と予測：コンポーネント別
11.6 アジア太平洋地域のAIを活用した創薬と臨床試験市場規模推定と予測：用途別
11.7 アジア太平洋地域のAIを活用した創薬・臨床試験市場規模推定と予測：治療分野別
11.8 アジア太平洋地域のAIを活用した創薬と臨床試験市場規模推定と予測：エンドユーザー別
11.9 中国 AIを活用した創薬・臨床試験の市場分析
11.10 日本のAIを活用した創薬と臨床試験の市場分析
11.11 インドのAI対応創薬・治験市場の分析
11.12 オーストラリアのAIを活用した創薬と臨床試験の市場分析
11.13 韓国のAIを活用した創薬と臨床試験の市場分析
11.14 シンガポールのAIを活用した創薬・臨床試験市場の分析
11.15 その他のアジア太平洋地域のAIを活用した創薬と臨床試験の市場分析
12 ラテンアメリカのAIを活用した創薬・臨床試験市場の分析
12.1 主要な調査結果
12.2 ラテンアメリカのAIを活用した創薬・臨床試験市場魅力度指数
12.3 ラテンアメリカのAIを活用した創薬・臨床試験市場の国別市場規模、2025年、2030年、2035年（百万米ドル）
12.4 ラテンアメリカのAIを活用した創薬・臨床試験市場規模国別推定と予測
12.5 ラテンアメリカのAIを活用した創薬・臨床試験市場規模予測と予測：コンポーネント別
12.6 ラテンアメリカのAIを活用した創薬・臨床試験市場規模推定と予測：用途別
12.7 ラテンアメリカのAIを活用した創薬・臨床試験市場規模推定と予測：治療分野別
12.8 ラテンアメリカのAIを活用した創薬・臨床試験市場規模推定と予測：エンドユーザー別
12.9 ブラジルのAIを活用した創薬・臨床試験市場分析
12.10 メキシコのAIを活用した創薬と臨床試験の市場分析
12.11 アルゼンチンのAIを活用した創薬・治験市場の分析
12.12 コロンビアのAIを活用した創薬と臨床試験の市場分析
12.13 その他のラテンアメリカのAIを活用した創薬と臨床試験の市場分析
13 MEAのAIを活用した創薬・臨床試験市場分析
13.1 主要な調査結果
13.2 MEAのAI対応創薬・臨床試験市場魅力度指数
13.3 MEAのAIを活用した創薬・臨床試験市場の国別市場規模、2025年、2030年、2035年（百万米ドル）
13.4 MEAのAIを活用した創薬・臨床試験市場規模国別推定と予測
13.5 MEAのAIを活用した創薬・臨床試験市場規模推定と予測：：コンポーネント別
13.6 MEAのAIを活用した創薬と臨床試験市場規模推定と予測：用途別
13.7 MEAのAIを活用した創薬と臨床試験市場規模推定と予測：治療分野別
13.8 MEAのAIを活用した創薬・臨床試験の市場規模推定と予測：エンドユーザー別
13.9 GCCのAIを活用した創薬・臨床試験市場分析
13.10 南アフリカのAIを活用した創薬・臨床試験市場の分析
13.11 その他のMEAのAIを活用した創薬・臨床試験市場の分析
14 主要企業のプロファイル
14.1 競争環境、2024年
14.2 戦略的展望
14.3 Recursion
14.3.1 会社概要
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 純収入、2020-2024年
14.3.3.2 R＆D、2020-2024年
14.3.4 製品・サービスのベンチマーク
14.3.5 戦略的展望
14.3.6 SWOT分析
14.4 Insilico Medicine
14.4.1 会社概要
14.4.2 会社概要
14.4.3 製品・サービスのベンチマーク
14.4.4 戦略的展望
14.4.5 SWOT分析
14.5 BenevolentAI
14.5.1 会社概要
14.5.2 会社概要
14.5.3 製品/サービスベンチマーク
14.5.4 戦略的展望
14.5.5 SWOT分析
14.6 Saama Technologies
14.6.1 会社概要
14.6.2 会社概要
14.6.3 製品／サービスのベンチマーキング
14.6.4 戦略的展望
14.7 Tempus
14.7.1 会社概要
14.7.2 会社概要
14.7.2.1 事業セグメント別市場シェア、2024年
14.7.3 製品／サービスのベンチマーキング
14.7.4 戦略的展望
14.7.5 SWOT分析
14.8 Unlearn.ai, Inc.
14.8.1 会社概要
14.8.2 会社概要
14.8.3 製品/サービスベンチマーク
14.8.4 戦略的展望
14.9 PathAI, Inc.
14.9.1 会社概要
14.9.2 会社概要
14.9.3 製品／サービスのベンチマーキング
14.9.4 戦略的展望
14.10 Atomwise Inc.
14.10.1 会社概要
14.10.2 会社概要
14.10.3 製品／サービス・ベンチマーク
14.11 Schrödinger, Inc.
14.11.1 会社概要
14.11.2 会社概要
14.11.3 財務分析
14.11.3.1 純収入、2020-2024年
14.11.3.2 売上高、2020-2024年
14.11.3.3 事業セグメント市場シェア、2024年
14.11.4 製品／サービスのベンチマーキング
14.11.5 戦略的展望
14.11.6 SWOT分析
14.12 AiCure
14.12.1 会社概要
14.12.2 会社概要
14.12.3 製品／サービスのベンチマーキング
14.12.4 戦略的展望
14.13 Aitia
14.13.1 会社概要
14.13.2 会社概要
14.13.3 製品／サービス・ベンチマーク
14.13.4 戦略的展望
15 結論と提言
15.1 Visiongainの結語
15.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
List of Tables
Table 1 AI-Enabled Drug Discovery and Clinical Trials Market Snapshot, 2025 & 2035 (US$ Million, CAGR %)
Table 2 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 3 Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 4 Software Solutions Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 5 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 6 Clinical Trials Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 7 Drug Design Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 8 Data Aggregation and Analysis Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 9 Drug Characterization Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 10 Biomarker Research Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 11 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 12 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 13 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 14 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 15 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 16 Neurodegenerative Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 17 Metabolic Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 18 Immunological Disorders Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 20 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 21 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 22 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 23 Academic Institutes and Research Centre Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 24 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 25 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 26 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Indication, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 27 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 28 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 29 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 30 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 31 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 32 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
Table 33 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 34 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 35 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 36 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 37 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 38 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 39 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 40 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 41 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 42 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 43 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 44 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
Table 45 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 46 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 47 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 48 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 49 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 50 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 51 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 52 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 53 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 54 Singapore AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 55 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 56 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
Table 57 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 58 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 59 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 60 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 61 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 62 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 63 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 64 Colombia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 65 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 66 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
Table 67 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 68 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 69 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 70 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 71 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 72 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 73 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 74 Strategic Outlook
Table 75 Recursion: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Recursion: Product/Service Benchmarking
Table 77 Recursion: Strategic Outlook
Table 78 Insilico Medicine: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Insilico Medicine: Product/Service Benchmarking
Table 80 Insilico Medicine: Strategic Outlook
Table 81 BenevolentAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 BenevolentAI: Product/Service Benchmarking
Table 83 BenevolentAI: Strategic Outlook
Table 84 Saama Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Saama Technologies: Product/Service Benchmarking
Table 86 Saama Technologies: Strategic Outlook
Table 87 Tempus: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Tempus: Product/Service Benchmarking
Table 89 Tempus: Strategic Outlook
Table 90 Unlearn.ai, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Unlearn.ai, Inc.: Product/Service Benchmarking
Table 92 Unlearn.ai, Inc.: Strategic Outlook
Table 93 PathAI, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 PathAI, Inc.: Product/Service Benchmarking
Table 95 PathAI, Inc.: Strategic Outlook
Table 96 Atomwise Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Atomwise Inc.: Product/Service Benchmarking
Table 98 Schrödinger, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Schrödinger, Inc.: Product/Service Benchmarking
Table 100 Schrödinger, Inc.: Strategic Outlook
Table 101 AiCure: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 AiCure: Product/Service Benchmarking
Table 103 AiCure: Strategic Outlook
Table 104 Aitia: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Aitia: Product/Service Benchmarking
Table 106 Aitia: Strategic Outlook
List of Figures
Figure 1 AI-Enabled Drug Discovery and Clinical Trials Market Segmentation
Figure 2 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
Figure 3 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
Figure 4 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
Figure 5 AI-Enabled Drug Discovery and Clinical Trials Market by End-users: Market Attractiveness Index
Figure 6 AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index by Region
Figure 7 AI-Enabled Drug Discovery and Clinical Trials Market: Market Dynamics
Figure 8 AI-Enabled Drug Discovery and Clinical Trials Market: Impact Analysis
Figure 9 AI-Enabled Drug Discovery and Clinical Trials Market: Porter’s Five Forces Analysis
Figure 10 AI-Enabled Drug Discovery and Clinical Trials Market: PEST Analysis
Figure 11 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
Figure 12 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 13 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025, 2030, 2035 (%)
Figure 14 Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 15 Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 16 Software Solutions Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 17 Software Solutions Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
Figure 19 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 20 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 21 Clinical Trials Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 22 Clinical Trials Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 23 Drug Design Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 24 Drug Design Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 Data Aggregation and Analysis Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 26 Data Aggregation and Analysis Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 27 Drug Characterization Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 28 Drug Design Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 29 Biomarker Research Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 30 Biomarker Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 32 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 33 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
Figure 34 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 35 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 36 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 37 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 38 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 39 Cardiovascular Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 41 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 42 Neurodegenerative Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 43 Neurodegenerative Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 44 Metabolic Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 45 Metabolic Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 46 Immunological Disorders Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 47 Immunological Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 48 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 49 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 50 AI-Enabled Drug Discovery and Clinical Trials Market by End-users: Market Attractiveness Index
Figure 51 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 52 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 53 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 54 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 55 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 56 Contract Research Organizations (CROs) Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 57 Academic Institutes and Research Centre Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 58 Academic Institutes and Research Centre Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 59 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region 2025 and 2035 (Revenue, CAGR%)
Figure 60 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 61 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025-2035 (US$ Million, AGR %)
Figure 62 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 63 North America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 64 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 65 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 66 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 67 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 68 North America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 69 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
Figure 70 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 71 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
Figure 72 North America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 73 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 74 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 75 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 76 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 77 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 78 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 79 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 80 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 81 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 82 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 83 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
Figure 84 Europe Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 85 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
Figure 86 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 87 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 88 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 89 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 90 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 91 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 92 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 93 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 94 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 95 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 96 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 97 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 98 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 99 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 100 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 101 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 102 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
Figure 103 Asia-Pacific Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 104 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 105 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 106 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
Figure 107 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 108 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 109 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 110 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 111 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 112 Singapore AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 113 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 114 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 115 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 116 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 117 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 118 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 119 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 120 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 121 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
Figure 122 Latin America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 123 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 124 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 125 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
Figure 126 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 127 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 128 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 129 Colombia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 130 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 131 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 132 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 133 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 134 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 135 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 136 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 137 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 138 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
Figure 139 MEA Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 140 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 141 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 142 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
Figure 143 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 144 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 145 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 146 AI-Enabled Drug Discovery and Clinical Trials Market: Company Share/Ranking, 2024
Figure 147 Recursion: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 148 Recursion: R&D, 2020-2024 (US$ Million, AGR%)
Figure 149 Recursion: SWOT Analysis
Figure 150 Insilico Medicine: SWOT Analysis
Figure 151 BenevolentAI: SWOT Analysis
Figure 152 Tempus: Business Segment Market Shares, 2024
Figure 153 Tempus: SWOT Analysis
Figure 154 Schrödinger, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 155 Schrödinger, Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 156 Schrödinger, Inc.: Business Segment Market Shares, 2024
Figure 157 Schrödinger, Inc.: SWOT Analysis
ページTOPに戻る
Summary
Description
The AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Accelerated Drug Development Timelines and Cost Efficiency Driving Market Growth
Key drivers propelling the AI-enabled drug discovery and clinical trials market include the ability to reduce drug development timelines, lower research costs, and improve operational efficiency. AI technology streamlines various phases of drug discovery, including target identification, molecule screening, and clinical trial optimization, leading to faster and more cost-effective drug development. Additionally, advancements in AI-driven platforms—such as generative models for molecular design and predictive analytics for patient recruitment—are expected to further boost market growth.
For instance:
-
On 24th March 2025, researchers at the Oxford Drug Discovery Institute have employed AI-powered databases to accelerate Alzheimer’s drug discovery. By efficiently analyzing extensive biomedical data, they identified 54 immune system-related genes for potential testing, significantly reducing the time required for gene evaluation and expediting the identification of promising drug targets.
-
On 21st March 2025, AstraZeneca announced a $2.5 billion investment over five years to establish a research and manufacturing center in Beijing, featuring an AI and data science laboratory. This initiative underscores the company’s commitment to leveraging AI for enhancing early-stage research and clinical development, aiming to expedite drug discovery and reduce associated costs.
-
On 8th January 2025, Advanced Micro Devices Inc. (AMD) invested $20 million in Absci Corp to enhance AI-backed drug discovery efforts. This collaboration aims to expedite biologics innovation and reduce costs by leveraging AMD’s advanced computing capabilities, highlighting the growing role of AI in transforming traditional drug development processes.
However, some large pharmaceutical companies remain hesitant to fully adopt AI-driven outsourcing due to concerns about data privacy, intellectual property loss, and reduced strategic control. Despite these concerns, the increasing complexity of drug development, combined with the rising costs of in-house operations, is pushing many companies to collaborate with AI solution providers to enhance efficiency and innovation. Emerging economies are also playing a critical role, as pharmaceutical firms seek to capitalize on lower operational costs and advanced AI technologies in these regions.
Regulatory and Data Integration Challenges to Hamper Market Growth
While the adoption of AI offers significant benefits, challenges around regulatory compliance, data integration, and standardization may slow market growth. Strict regulations governing drug approval and patient data protection require AI systems to maintain transparency and explainability, adding layers of complexity to implementation. Additionally, the need for harmonized data across diverse systems and geographies poses a logistical challenge for AI-enabled platforms.
Ensuring real-time collaboration between AI platforms and clinical trial sites also requires robust data infrastructure and seamless integration. For instance, personalized medicine and rare disease trials require advanced AI models capable of managing vast datasets while adhering to stringent regulatory frameworks. As AI adoption grows, industry stakeholders must navigate these administrative and technical challenges to fully realize the potential of AI in drug discovery and clinical trials.
What Questions Should You Ask before Buying a Market Research Report?
-
How is the AI-enabled drug discovery and clinical trials market evolving?
-
What is driving and restraining the AI-enabled drug discovery and clinical trials market?
-
How will each AI-enabled drug discovery and clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
-
How will the market shares for each AI-enabled drug discovery and clinical trials submarket develop from 2025 to 2035?
-
What will be the main driver for the overall market from 2025 to 2035?
-
Will leading AI-enabled drug discovery and clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
-
How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
-
Who are the leading players and what are their prospects over the forecast period?
-
What are the AI-enabled drug discovery and clinical trials projects for these leading companies?
-
How will the industry evolve during the period between 2025 and 2035? What are the implications of AI-enabled drug discovery and clinical trials projects taking place now and over the next 10 years?
-
Is there a greater need for product commercialisation to further scale the AI-enabled drug discovery and clinical trials market?
-
Where is the AI-enabled drug discovery and clinical trials market heading and how can you ensure you are at the forefront of the market?
-
What are the best investment options for new product and service lines?
-
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the AI-Enabled Drug Discovery and Clinical Trials market today, and over the next 10 years:
-
Our 285-page report provides 107 tables and 155 charts/graphs exclusively to you.
-
The report highlights key lucrative areas in the industry so you can target them – NOW.
-
It contains in-depth analysis of global, regional and national sales and growth.
-
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2035 and other analyses reveal commercial prospects
-
In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
-
You will find original analyses, with business outlooks and developments.
-
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI-Enabled Drug Discovery and Clinical Trials prices and recent developments.
Segments Covered in the Report
Component
-
Services
-
Software Solutions
Application
-
Clinical Trials
-
Drug Design
-
Data Aggregation and Analysis
-
Drug Characterisation
-
Biomarker Research
-
Others
Therapeutic Area
-
Oncology
-
Cardiovascular Diseases
-
Infectious Diseases
-
Neurodegenerative Diseases
-
Metabolic Diseases
-
Immunological Disorders
-
Others
End-users
-
Pharmaceutical & Biopharmaceutical Companies
-
Contract Research Organisations (CROs)
-
Academic Institutes and Research Centre
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:
North America
Europe
-
Germany
-
UK
-
France
-
Spain
-
Russia
-
Italy
-
Rest of Europe
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Singapore
-
Rest of Asia Pacific
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Colombia
-
Rest of Latin America
MEA
-
GCC
-
South Africa
-
Rest of MEA
The report also includes profiles and for some of the leading companies in the AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035, with a focus on this segment of these companies’ operations.
Leading companies profiled in the report
-
AiCure
-
Aitia
-
Atomwise Inc.
-
BenevolentAI
-
Insilico Medicine
-
PathAI, Inc.
-
Recursion
-
Saama Technologies
-
Schrödinger, Inc.
-
Tempus
-
Unlearn.ai, Inc.
Overall world revenue for AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035 in terms of value the market will surpass US$3,000 million in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035 report help you?
In summary, our 280+ page report provides you with the following knowledge:
-
Revenue forecasts to 2035 for AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035, with forecasts for component, application, therapeutic area, and end-users each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
-
Revenue forecasts to 2035 for five regional and 24 key national markets – See forecasts for the AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
-
Prospects for established firms and those seeking to enter the market – including company profiles for 11 of the major companies involved in the AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
ページTOPに戻る
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to AI-Enabled Drug Discovery and Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Growing Focus on Personalized Medicine
3.3.1.2 Advancements in Technology
3.3.1.3 Growing Adoption of AI in Healthcare
3.3.2 Market Restraining Factors
3.3.2.1 Limited Data Availability and Quality
3.3.2.2 Integration with Existing Infrastructure
3.3.2.3 Concerns over Data Privacy and Security
3.3.3 Market Opportunities
3.3.3.1 Improved Patient Outcomes
3.3.3.2 Increasing AI adoption in Pharma and Biopharma Clinical Trials
3.3.3.3 Growing Collaborations and Partnerships
3.4 Regulatory Framework
3.5 Emerging Markets and Megatrends
3.6 Porter’s Five Forces Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitutes
3.6.5 Threat of New Entrants
3.7 PEST Analysis
4 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Component
4.1 Key Findings
4.2 Component Segment: Market Attractiveness Index
4.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
4.4 Services
4.4.1 Market Size by Region, 2025-2035 (US$ Million)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.5 Software Solutions
4.5.1 Market Size by Region, 2025-2035 (US$ Million)
4.5.2 Market Share by Region, 2025 & 2035 (%)
5 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
5.4 Clinical Trials
5.4.1 Market Size by Region, 2025-2035 (US$ Million)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Drug Design
5.5.1 Market Size by Region, 2025-2035 (US$ Million)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Data Aggregation and Analysis
5.6.1 Market Size by Region, 2025-2035 (US$ Million)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Drug Characterization
5.7.1 Market Size by Region, 2025-2035 (US$ Million)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Biomarker Research
5.8.1 Market Size by Region, 2025-2035 (US$ Million)
5.8.2 Market Share by Region, 2025 & 2035 (%)
5.9 Others
5.9.1 Market Size by Region, 2025-2035 (US$ Million)
5.9.2 Market Share by Region, 2025 & 2035 (%)
6 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1 Market Size by Region, 2025-2035 (US$ Million)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Cardiovascular Diseases
6.5.1 Market Size by Region, 2025-2035 (US$ Million)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Infectious Diseases
6.6.1 Market Size by Region, 2025-2035 (US$ Million)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Neurodegenerative Diseases
6.7.1 Market Size by Region, 2025-2035 (US$ Million)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Metabolic Diseases
6.8.1 Market Size by Region, 2025-2035 (US$ Million)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Immunological Disorders
6.9.1 Market Size by Region, 2025-2035 (US$ Million)
6.9.2 Market Share by Region, 2025 & 2035 (%)
6.10 Others
6.10.1 Market Size by Region, 2025-2035 (US$ Million)
6.10.2 Market Share by Region, 2025 & 2035 (%)
7 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
7.4 Pharmaceutical & Biopharmaceutical Companies
7.4.1 Market Size by Region, 2025-2035 (US$ Million)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 Contract Research Organizations (CROs)
7.5.1 Market Size by Region, 2025-2035 (US$ Million)
7.5.2 Market Share by Region, 2025 & 2035 (%)
7.6 Academic Institutes and Research Centre
7.6.1 Market Size by Region, 2025-2035 (US$ Million)
7.6.2 Market Share by Region, 2025 & 2035 (%)
8 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America AI-Enabled Drug Discovery and Clinical Trials Market Analysis
9.1 Key Findings
9.2 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
9.3 North America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
9.4 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
9.5 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
9.6 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
9.7 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
9.8 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
9.9 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Analysis
9.10 Canada AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10 Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.1 Key Findings
10.2 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
10.3 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
10.4 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
10.5 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
10.6 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
10.7 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
10.8 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
10.9 Germany AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.10 UK AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.11 France AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.12 Italy AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.13 Spain AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.14 Russia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.15 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.1 Key Findings
11.2 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
11.3 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
11.4 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
11.5 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
11.6 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
11.7 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
11.8 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
11.9 China AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.10 Japan AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.11 India AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.12 Australia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.13 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.14 Singapore AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.15 Rest of Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.1 Key Findings
12.2 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
12.3 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
12.4 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
12.5 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
12.6 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
12.7 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
12.8 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
12.9 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.10 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.11 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.12 Colombia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.13 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13 MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.1 Key Findings
13.2 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
13.3 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
13.4 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
13.5 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
13.6 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
13.7 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
13.8 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
13.9 GCC AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.10 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.11 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2024
14.2 Strategic Outlook
14.3 Recursion
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2020-2024
14.3.3.2 R&D, 2020-2024
14.3.4 Product/Service Benchmarking
14.3.5 Strategic Outlook
14.3.6 SWOT Analysis
14.4 Insilico Medicine
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product/Service Benchmarking
14.4.4 Strategic Outlook
14.4.5 SWOT Analysis
14.5 BenevolentAI
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product/Service Benchmarking
14.5.4 Strategic Outlook
14.5.5 SWOT Analysis
14.6 Saama Technologies
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Product/Service Benchmarking
14.6.4 Strategic Outlook
14.7 Tempus
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.2.1 Business Segment Market Shares, 2024
14.7.3 Product/Service Benchmarking
14.7.4 Strategic Outlook
14.7.5 SWOT Analysis
14.8 Unlearn.ai, Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product/Service Benchmarking
14.8.4 Strategic Outlook
14.9 PathAI, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product/Service Benchmarking
14.9.4 Strategic Outlook
14.10 Atomwise Inc.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product/Service Benchmarking
14.11 Schrödinger, Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2020-2024
14.11.3.2 R&D, 2020-2024
14.11.3.3 Business Segment Market Shares, 2024
14.11.4 Product/Service Benchmarking
14.11.5 Strategic Outlook
14.11.6 SWOT Analysis
14.12 AiCure
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product/Service Benchmarking
14.12.4 Strategic Outlook
14.13 Aitia
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product/Service Benchmarking
14.13.4 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 AI-Enabled Drug Discovery and Clinical Trials Market Snapshot, 2025 & 2035 (US$ Million, CAGR %)
Table 2 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 3 Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 4 Software Solutions Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 5 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 6 Clinical Trials Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 7 Drug Design Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 8 Data Aggregation and Analysis Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 9 Drug Characterization Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 10 Biomarker Research Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 11 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 12 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 13 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 14 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 15 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 16 Neurodegenerative Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 17 Metabolic Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 18 Immunological Disorders Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 20 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 21 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 22 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 23 Academic Institutes and Research Centre Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 24 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 25 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 26 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Indication, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 27 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 28 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 29 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 30 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 31 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 32 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
Table 33 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 34 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 35 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 36 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 37 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 38 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 39 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 40 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 41 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 42 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 43 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 44 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
Table 45 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 46 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 47 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 48 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 49 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 50 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 51 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 52 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 53 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 54 Singapore AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 55 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 56 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
Table 57 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 58 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 59 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 60 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 61 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 62 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 63 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 64 Colombia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 65 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 66 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
Table 67 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 68 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 69 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 70 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 71 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 72 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 73 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 74 Strategic Outlook
Table 75 Recursion: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Recursion: Product/Service Benchmarking
Table 77 Recursion: Strategic Outlook
Table 78 Insilico Medicine: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Insilico Medicine: Product/Service Benchmarking
Table 80 Insilico Medicine: Strategic Outlook
Table 81 BenevolentAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 BenevolentAI: Product/Service Benchmarking
Table 83 BenevolentAI: Strategic Outlook
Table 84 Saama Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Saama Technologies: Product/Service Benchmarking
Table 86 Saama Technologies: Strategic Outlook
Table 87 Tempus: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Tempus: Product/Service Benchmarking
Table 89 Tempus: Strategic Outlook
Table 90 Unlearn.ai, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Unlearn.ai, Inc.: Product/Service Benchmarking
Table 92 Unlearn.ai, Inc.: Strategic Outlook
Table 93 PathAI, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 PathAI, Inc.: Product/Service Benchmarking
Table 95 PathAI, Inc.: Strategic Outlook
Table 96 Atomwise Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Atomwise Inc.: Product/Service Benchmarking
Table 98 Schrödinger, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Schrödinger, Inc.: Product/Service Benchmarking
Table 100 Schrödinger, Inc.: Strategic Outlook
Table 101 AiCure: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 AiCure: Product/Service Benchmarking
Table 103 AiCure: Strategic Outlook
Table 104 Aitia: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Aitia: Product/Service Benchmarking
Table 106 Aitia: Strategic Outlook
List of Figures
Figure 1 AI-Enabled Drug Discovery and Clinical Trials Market Segmentation
Figure 2 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
Figure 3 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
Figure 4 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
Figure 5 AI-Enabled Drug Discovery and Clinical Trials Market by End-users: Market Attractiveness Index
Figure 6 AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index by Region
Figure 7 AI-Enabled Drug Discovery and Clinical Trials Market: Market Dynamics
Figure 8 AI-Enabled Drug Discovery and Clinical Trials Market: Impact Analysis
Figure 9 AI-Enabled Drug Discovery and Clinical Trials Market: Porter’s Five Forces Analysis
Figure 10 AI-Enabled Drug Discovery and Clinical Trials Market: PEST Analysis
Figure 11 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
Figure 12 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 13 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025, 2030, 2035 (%)
Figure 14 Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 15 Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 16 Software Solutions Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 17 Software Solutions Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
Figure 19 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 20 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 21 Clinical Trials Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 22 Clinical Trials Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 23 Drug Design Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 24 Drug Design Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 Data Aggregation and Analysis Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 26 Data Aggregation and Analysis Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 27 Drug Characterization Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 28 Drug Design Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 29 Biomarker Research Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 30 Biomarker Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 32 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 33 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
Figure 34 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 35 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 36 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 37 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 38 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 39 Cardiovascular Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 41 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 42 Neurodegenerative Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 43 Neurodegenerative Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 44 Metabolic Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 45 Metabolic Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 46 Immunological Disorders Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 47 Immunological Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 48 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 49 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 50 AI-Enabled Drug Discovery and Clinical Trials Market by End-users: Market Attractiveness Index
Figure 51 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 52 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 53 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 54 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 55 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 56 Contract Research Organizations (CROs) Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 57 Academic Institutes and Research Centre Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 58 Academic Institutes and Research Centre Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 59 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region 2025 and 2035 (Revenue, CAGR%)
Figure 60 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 61 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025-2035 (US$ Million, AGR %)
Figure 62 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 63 North America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 64 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 65 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 66 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 67 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 68 North America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 69 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
Figure 70 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 71 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
Figure 72 North America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 73 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 74 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 75 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 76 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 77 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 78 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 79 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 80 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 81 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 82 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 83 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
Figure 84 Europe Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 85 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
Figure 86 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 87 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 88 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 89 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 90 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 91 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 92 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 93 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 94 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 95 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 96 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 97 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 98 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 99 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 100 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 101 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 102 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
Figure 103 Asia-Pacific Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 104 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 105 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 106 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
Figure 107 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 108 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 109 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 110 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 111 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 112 Singapore AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 113 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 114 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 115 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 116 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 117 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 118 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 119 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 120 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 121 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
Figure 122 Latin America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 123 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 124 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 125 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
Figure 126 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 127 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 128 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 129 Colombia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 130 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 131 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 132 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
Figure 133 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
Figure 134 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
Figure 135 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
Figure 136 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
Figure 137 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
Figure 138 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
Figure 139 MEA Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 140 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 141 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 142 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
Figure 143 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 144 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 145 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 146 AI-Enabled Drug Discovery and Clinical Trials Market: Company Share/Ranking, 2024
Figure 147 Recursion: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 148 Recursion: R&D, 2020-2024 (US$ Million, AGR%)
Figure 149 Recursion: SWOT Analysis
Figure 150 Insilico Medicine: SWOT Analysis
Figure 151 BenevolentAI: SWOT Analysis
Figure 152 Tempus: Business Segment Market Shares, 2024
Figure 153 Tempus: SWOT Analysis
Figure 154 Schrödinger, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 155 Schrödinger, Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 156 Schrödinger, Inc.: Business Segment Market Shares, 2024
Figure 157 Schrödinger, Inc.: SWOT Analysis
ページTOPに戻る
本レポートと同分野（医療IT）の最新刊レポート
- 経カテーテル大動脈弁置換市場 - 世界の産業分析、規模、シェア、成長、動向、2032年予測 - 製品別, 技術別, グレード別, 用途別, エンドユーザー別, 地域別: (北米, 欧州, アジア太平洋, 中南米, 中東アフリカ)
- 乳房病変局在化法市場 - 世界の産業分析、規模、シェア、成長、動向、2032年予測 - 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別：（北米、欧州、アジア太平洋地域、中南米、中東・アフリカ）
- 下肢補綴市場 - 世界の産業分析、規模、シェア、成長、動向、2032年予測 - 製品別, 技術別, グレード別, 用途別, エンドユーザー別, 地域別: (北米, 欧州, アジア太平洋, 中南米, 中東アフリカ)
- 血中ケトン測定器市場 - 世界の産業分析、市場規模、シェア、成長、動向、2032年予測 - 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別：（北米、欧州、アジア太平洋、中南米、中東アフリカ）
- 炎症性腸疾患市場 - 世界の産業分析、規模、シェア、成長、動向、2032年予測 - 製品別, 技術別, グレード別, 用途別, エンドユーザー別, 地域別：（北米, 欧州, アジア太平洋, 中南米, 中東アフリカ）
- ウェアラブル血圧モニタリングデバイス市場 - 世界の産業分析、規模、シェア、成長、動向、2032年予測 - 製品別, 技術別, グレード別, 用途別, エンドユーザー別, 地域別: (北米, 欧州, アジア太平洋, 中南米, 中東アフリカ)
- 経皮皮膚パッチ市場 - 世界の産業分析、規模、シェア、成長、動向、2032年予測 - 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別：（北米、欧州、アジア太平洋地域、中南米、中東・アフリカ）
- 欧州脳卒中診断市場 - 産業分析、規模、シェア、成長、動向、2032年予測 - 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別：（ヨーロッパ）
- 結核診断薬市場 - 世界の産業分析、規模、シェア、成長、動向、2032年予測 - 製品別, 技術別, グレード別, 用途別, エンドユーザー別, 地域別：（北米, 欧州, アジア太平洋, 中南米, 中東アフリカ）
- サル痘（mpox）診断市場 - 世界の産業分析、市場規模、シェア、成長、動向、2032年予測 - 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別：（北米、欧州、アジア太平洋地域、中南米、中東・アフリカ）
Visiongain社のヘルスケアと医薬・化学品分野での最新刊レポート
本レポートと同じKEY WORD（drug）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
